A lawyer for John Kapoor, Insys Therapeutics Inc.’s one-time billionaire founder, denied that Kapoor had any role in the U.S. opioid crisis on Jan. 28 as a federal prosecutor told jurors he ran a scheme to bribe doctors to prescribe an addictive fentanyl spray.
Kapoor, the drugmaker’s former chairman, and four colleagues are the first painkiller manufacturer executives to face trial over conduct authorities say contributed to an opioid abuse crisis that has killed tens of thousands of people in 2017 alone.
